It's Jim Kramer here. You're listening to the opening bell of CNBC Squawk on the Street.

Don't miss a minute of the action.

Good Monday morning. Welcome to Squawk on the Street. I'm Carl Kintene with Jim Kramer, David

Favored, the New York Stock Exchange. Futures start the week with the bounce as the Chinese premiere

cites substantial progress in trade talks.

Buckle up for a busy earnings week.

You've got a quarter of the S&P reporting in the coming days.

What a weekend in the UK?

The pounds trying to hold $1.30 after Parliament's vote.

And the tenure, 178, is about a one-month high.

Our roadmap begins with new pressures for Boeing, downgrades at Credit Suisse and UBS today.

Some renewed congressional scrutiny shares tumbling 10% on the past week.

Plus opioids on trial in Ohio for drug companies reaching a last-minute settlement ahead of what was the landmark first federal opioid case.

And Mark Zuckerberg speaking out why the Facebook CEO tells NBC News, quote,

it's more important to be understood than it is to be liked. Shares of Boeing are under pressure,

having its worst day in more than two and a half years, losing almost 7% Friday. As we said,

Credit Suisse and UBS both cut the stock to neutral from by today. Boeing remains under scrutiny

following the revelations of those emails from 2016, which called into question the safety

of the 737 Max Jets flight control system. The board met over the weekend, expressed regret

over the message, continuing to investigate. Dennis Mullenberg is scheduled to testify

at House Transportation next week.

Reuters suggest that this board meeting in Texas may consider things like job cuts and some other

...